Related Experiment Video
Updated: Jul 10, 2026
11:35
The Multiple Sclerosis Performance Test (MSPT): An iPad-Based Disability Assessment Tool
Published on: June 30, 2014
Understanding the financial impact of MS-DRGs
13M Consulting Services, 3M Health Information Systems, Inc., Atlanta, USA. kcmitchell@mmm.com
Summary
Hospitals should analyze product line data to identify trends and determine the impact of changes to Medicare's inpatient prospective payment system. Proactive action plans are essential for managing resulting revenue shifts.
Area of Science:
- Healthcare Administration
- Health Economics
- Hospital Management
Background:
- Medicare's inpatient prospective payment system (IPPS) significantly impacts hospital revenue.
- Understanding and adapting to IPPS changes is crucial for financial stability.
Purpose of the Study:
- To outline actionable steps for hospitals preparing for IPPS modifications.
- To guide healthcare providers in revenue management amidst payment system evolution.
Main Methods:
- Data analysis within hospital product lines.
- Identification of trends by physician and Medicare severity diagnosis-related groups (MS-DRGs).
- Assessment of product line vulnerability to payment system changes.
Main Results:
- Key product lines susceptible to revenue changes can be identified through data analysis.
- Specific physician groups or MS-DRGs may experience disproportionate impacts.
- Proactive planning enables effective management of financial adjustments.
Conclusions:
- Hospitals must conduct thorough data analysis to anticipate IPPS-related financial shifts.
- Strategic planning based on identified trends is vital for mitigating revenue risks.
- Adapting to Medicare payment system changes requires a data-driven approach.
Related Concept Videos
01:15Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).
01:19Multiple Sclerosis l: Introduction
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
01:29Therapeutic Drug Monitoring: Affecting Factors
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
01:28Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration
Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area. This equation is...